227 related articles for article (PubMed ID: 27461042)
1. Leveraging Mechanisms Governing Pancreatic Tumorigenesis To Reduce Pancreatic Cancer Mortality.
Donahue TR; Dawson DW
Trends Endocrinol Metab; 2016 Nov; 27(11):770-781. PubMed ID: 27461042
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice.
Collins MA; Bednar F; Zhang Y; Brisset JC; Galbán S; Galbán CJ; Rakshit S; Flannagan KS; Adsay NV; Pasca di Magliano M
J Clin Invest; 2012 Feb; 122(2):639-53. PubMed ID: 22232209
[TBL] [Abstract][Full Text] [Related]
3. Critical role of oncogenic KRAS in pancreatic cancer (Review).
Liu J; Ji S; Liang C; Qin Y; Jin K; Liang D; Xu W; Shi S; Zhang B; Liu L; Liu C; Xu J; Ni Q; Yu X
Mol Med Rep; 2016 Jun; 13(6):4943-9. PubMed ID: 27121414
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells.
Ji Z; Mei FC; Xie J; Cheng X
J Biol Chem; 2007 May; 282(19):14048-55. PubMed ID: 17353198
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.
Luo Y; Yang Y; Liu M; Wang D; Wang F; Bi Y; Ji J; Li S; Liu Y; Chen R; Huang H; Wang X; Swidnicka-Siergiejko AK; Janowitz T; Beyaz S; Wang G; Xu S; Bialkowska AB; Luo CK; Pin CL; Liang G; Lu X; Wu M; Shroyer KR; Wolff RA; Plunkett W; Ji B; Li Z; Li E; Li X; Yang VW; Logsdon CD; Abbruzzese JL; Lu W
Gastroenterology; 2019 Nov; 157(5):1413-1428.e11. PubMed ID: 31352001
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment.
Dey P; Li J; Zhang J; Chaurasiya S; Strom A; Wang H; Liao WT; Cavallaro F; Denz P; Bernard V; Yen EY; Genovese G; Gulhati P; Liu J; Chakravarti D; Deng P; Zhang T; Carbone F; Chang Q; Ying H; Shang X; Spring DJ; Ghosh B; Putluri N; Maitra A; Wang YA; DePinho RA
Cancer Discov; 2020 Apr; 10(4):608-625. PubMed ID: 32046984
[TBL] [Abstract][Full Text] [Related]
7. Interplay between MAP kinases and tumor microenvironment: Opportunity for immunotherapy in pancreatic cancer.
Kumar S; Singh SK; Srivastava P; Suresh S; Rana B; Rana A
Adv Cancer Res; 2023; 159():113-143. PubMed ID: 37268394
[TBL] [Abstract][Full Text] [Related]
8. Stromal response to Hedgehog signaling restrains pancreatic cancer progression.
Lee JJ; Perera RM; Wang H; Wu DC; Liu XS; Han S; Fitamant J; Jones PD; Ghanta KS; Kawano S; Nagle JM; Deshpande V; Boucher Y; Kato T; Chen JK; Willmann JK; Bardeesy N; Beachy PA
Proc Natl Acad Sci U S A; 2014 Jul; 111(30):E3091-100. PubMed ID: 25024225
[TBL] [Abstract][Full Text] [Related]
9. The PRKD1 promoter is a target of the KRas-NF-κB pathway in pancreatic cancer.
Döppler H; Panayiotou R; Reid EM; Maimo W; Bastea L; Storz P
Sci Rep; 2016 Sep; 6():33758. PubMed ID: 27649783
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog/Ras interactions regulate early stages of pancreatic cancer.
Pasca di Magliano M; Sekine S; Ermilov A; Ferris J; Dlugosz AA; Hebrok M
Genes Dev; 2006 Nov; 20(22):3161-73. PubMed ID: 17114586
[TBL] [Abstract][Full Text] [Related]
11. ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis.
Wang L; Yang H; Zamperone A; Diolaiti D; Palmbos PL; Abel EV; Purohit V; Dolgalev I; Rhim AD; Ljungman M; Hadju CH; Halbrook CJ; Bar-Sagi D; di Magliano MP; Crawford HC; Simeone DM
Genes Dev; 2019 Jun; 33(11-12):641-655. PubMed ID: 31048544
[TBL] [Abstract][Full Text] [Related]
12. RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer.
Kang R; Hou W; Zhang Q; Chen R; Lee YJ; Bartlett DL; Lotze MT; Tang D; Zeh HJ
Cell Death Dis; 2014 Oct; 5(10):e1480. PubMed ID: 25341034
[TBL] [Abstract][Full Text] [Related]
13. KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.
Eibl G; Rozengurt E
Semin Cancer Biol; 2019 Feb; 54():50-62. PubMed ID: 29079305
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation.
Tape CJ; Ling S; Dimitriadi M; McMahon KM; Worboys JD; Leong HS; Norrie IC; Miller CJ; Poulogiannis G; Lauffenburger DA; Jørgensen C
Cell; 2016 May; 165(4):910-20. PubMed ID: 27087446
[TBL] [Abstract][Full Text] [Related]
15. Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities.
Bournet B; Buscail C; Muscari F; Cordelier P; Buscail L
Eur J Cancer; 2016 Feb; 54():75-83. PubMed ID: 26735353
[TBL] [Abstract][Full Text] [Related]
16. Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo.
Qiu W; Sahin F; Iacobuzio-Donahue CA; Garcia-Carracedo D; Wang WM; Kuo CY; Chen D; Arking DE; Lowy AM; Hruban RH; Remotti HE; Su GH
Oncotarget; 2011 Nov; 2(11):862-73. PubMed ID: 22113502
[TBL] [Abstract][Full Text] [Related]
17. EGF receptor is required for KRAS-induced pancreatic tumorigenesis.
Ardito CM; Grüner BM; Takeuchi KK; Lubeseder-Martellato C; Teichmann N; Mazur PK; Delgiorno KE; Carpenter ES; Halbrook CJ; Hall JC; Pal D; Briel T; Herner A; Trajkovic-Arsic M; Sipos B; Liou GY; Storz P; Murray NR; Threadgill DW; Sibilia M; Washington MK; Wilson CL; Schmid RM; Raines EW; Crawford HC; Siveke JT
Cancer Cell; 2012 Sep; 22(3):304-17. PubMed ID: 22975374
[TBL] [Abstract][Full Text] [Related]
18. SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer.
Zhou H; Qin Y; Ji S; Ling J; Fu J; Zhuang Z; Fan X; Song L; Yu X; Chiao PJ
Oncogene; 2018 Feb; 37(7):912-923. PubMed ID: 29059173
[TBL] [Abstract][Full Text] [Related]
19. Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma.
Liu YH; Hu CM; Hsu YS; Lee WH
Cell Death Dis; 2022 Sep; 13(9):817. PubMed ID: 36151074
[TBL] [Abstract][Full Text] [Related]
20. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function.
Viale A; Pettazzoni P; Lyssiotis CA; Ying H; Sánchez N; Marchesini M; Carugo A; Green T; Seth S; Giuliani V; Kost-Alimova M; Muller F; Colla S; Nezi L; Genovese G; Deem AK; Kapoor A; Yao W; Brunetto E; Kang Y; Yuan M; Asara JM; Wang YA; Heffernan TP; Kimmelman AC; Wang H; Fleming JB; Cantley LC; DePinho RA; Draetta GF
Nature; 2014 Oct; 514(7524):628-32. PubMed ID: 25119024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
